about
Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy.VERO® radiotherapy for low burden cancer: 789 patients with 957 lesionsHypoxia dose painting in prostate and cervix cancer.A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy.First evaluation of the feasibility of MLC tracking using ultrasound motion estimation.Hypofractionation trials and radiobiology of prostate cancer.Safety and feasibility of prostate stereotactic ablative radiotherapy using multimodality imaging and flattening filter free.Implanted fiducial markers are no longer needed for prostate cancer radiotherapy.Clinical usefulness of MLCs in robotic radiosurgery systems for prostate SBRT.Dosimetric Implications of Computerised Tomography-Only versus Magnetic Resonance-Fusion Contouring in Stereotactic Body Radiotherapy for Prostate Cancer.
P2860
Q37175207-D1DCC29C-0CF5-4E48-B604-074E60FB7A8EQ37301542-E9113A22-18A4-4AE7-B635-536349CC034BQ38413800-2B710785-4A5A-4D75-A818-62E36B8ABDADQ38640375-75161EFC-92EB-4A11-976F-390B01C427E7Q39528580-20D012B8-2842-4E9E-9F98-C4B712ACDE64Q42347543-CC55A3FB-DCAA-4BF4-B9F2-F1A09C1E368AQ48233697-1F15CB9F-359F-4AFB-B023-E416303AC37EQ50088298-0563D411-F3CD-4ED3-8309-760ADC126733Q50539419-7B0C84C3-54B9-48D8-B111-37EC6C752B50Q55425041-F80CFDAD-A169-478A-8F08-0D8114821291
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Stereotactic body radiotherapy for prostate cancer.
@en
type
label
Stereotactic body radiotherapy for prostate cancer.
@en
prefLabel
Stereotactic body radiotherapy for prostate cancer.
@en
P1433
P1476
Stereotactic body radiotherapy for prostate cancer
@en
P2093
D R Henderson
P304
P356
10.1016/J.CLON.2015.01.011
P577
2015-02-21T00:00:00Z